This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2012 by Red Rock Fertility Center.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Watson Pharmaceuticals
Information provided by (Responsible Party):
Red Rock Fertility Center
ClinicalTrials.gov Identifier:
NCT01513954
First received: January 17, 2012
Last updated: NA
Last verified: January 2012
History: No changes posted
January 17, 2012
January 17, 2012
January 2012
January 2013   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration
Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration
The purpose of this study is to determine whether progesterone hormone levels differ following egg retrieval with a single lumen needle compared with a double lumen needle. These levels will be measured on several days before and after egg retrieval. The progesterone levels in each IVF group will also be compared to the group of women who are having IUI. In addition, these progesterone levels will be correlated with pregnancy outcomes.
This is a prospective randomized trial consisting of 3 groups of patients. Following a long lupron protocol IVF cycle there is a need for supplemental progesterone. The purpose of this study is to determine what range of serum levels should be observed when differing methods of egg aspiration have been administered and whether or not there is a correlation with outcomes or pregnancies.
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
IUI patients and IVF patients following a long lupron protocol cycle
Infertility, Female
Not Provided
  • IVF population
    Long Lupron IVF Population
  • IUI patients
    Patients undergoing IUI
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
450
June 2013
January 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Ages between 21-37
  • Cycle Day 3 FSH between 2-12
  • History of regular menstrual cycles between 24-34 days

Exclusion Criteria:

  • Previous IVF failure
  • Severe male factor
  • Severe obesity, BMI > 40
  • More than 20 follicles on ultrasound prior to retrieval
Sexes Eligible for Study: Female
21 Years to 37 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01513954
20111821
Yes
Not Provided
Not Provided
Red Rock Fertility Center
Red Rock Fertility Center
Watson Pharmaceuticals
Principal Investigator: Eva D Littman, M.D. Red Rock Fertility Center
Red Rock Fertility Center
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP